Merge Labs · 19 hours ago
Scientist - Immunology
Merge Labs is a frontier research lab focused on bridging biological and artificial intelligence to enhance human capabilities. The Immunologist will design and validate biological strategies for immune tolerance related to brain-computer interfaces, collaborating with various teams to ensure compatibility and performance.
BiotechnologyHuman ResourcesSoftware
Responsibilities
Characterize the immunogenicity of engineered proteins, establishing quantitative readouts and benchmarks for immune compatibility in relevant in vitro and in vivo experimental models
Scale high-throughput immune characterization assays and workflows to enable rapid hypothesis testing and iteration
Collaborate with our computational and protein engineering teams to design and execute strategies to enhance immunological tolerance to molecular components of next-generation brain-computer interfaces to improve human compatibility
Drive technical ownership of projects from concept to execution, including experimental planning, prioritization, documentation, and clear communication of results
Qualification
Required
Have a PhD in Immunology, Bioengineering, or a related field, or have equivalent experience leading research projects end-to-end
Are proficient in designing, executing, and interpreting in vitro and in vivo experiments that interrogate immune responses, with strong experimental rigor and quantitative reasoning
Are comfortable contributing to the design and evaluation of innovative solutions aimed at promoting immune tolerance
Think mechanistically: you are motivated by understanding how things work, not just that they work
Feel joy in collaboration and communicate naturally with experts across disciplines
Are energized by 0->1 innovations and always on the lookout for creative ways to do better
Want to be part of a fast-paced team working on frontier scientific and technical problems
Company
Merge Labs
Merge Labs provides a single API to connect software applications with multiple third-party platforms.
Funding
Current Stage
Early StageTotal Funding
$252MKey Investors
OpenAI
2026-01-15Seed· $252M
Recent News
Company data provided by crunchbase